Edward Spangenthal, MD

PrintE-mail
Instructor, Department of Medicine
Roswell Park Cancer Institute
Clinical Instructor of Medicine
School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Profile

Areas of Expertise: 
Cardiology
Echocardiography

Research

Research Interests: 
Clinical and non-invasive cardiology
Cardiology care of the cancer patient
Echocardiography
Transesophageal echo and stress echo

Background Information

Education and Training: 
MD - State University of New York, Upstate Medical University, Syracuse, NY
Residency: 
Strong Memorial Hospital, University of Rochester, Rochester, NY
Board Certification: 
Internal Medicine, American Board of Internal Medicine
Cardiovascular Disease, American Board of Internal Medicine
Fellowships: 
School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Publications

Publications: 
  • Francis J, Spangenthal E, Cohen IL, McCarthy PL, Smiley S, Paplham P, Wang E, Wetzler M, Ahluwalia MS, Battiwalla M. Reversible cardiotoxicity with tyrosine kinase inhibitors. Clinical advances in hematology and oncology : H&O 2010; 8(2):128-132
  • Paulus A, Swaika A, Miller KC, Spangenthal EJ, Guo R, Vonfricken K, Lee K, Chanan-Khan AA. Clinical relapse in a patient with multiple myeloma presenting as an atrial plasmacytoma. Journal of clinical oncology 2011; 29(3):e47-e49
  • Jarkowski III A, Glode AE, Spangenthal EJ, Wong MKK. Heart failure caused by molecularly targeted therapies for cancer. Pharmacotherapy 2011; 31(1):62-75
  • Pande A, Lombardo J, Spangenthal E, Javle M. Hypertension secondary to anti-angiogenic therapy: experience with bevacizumab. Anticancer research 2007; 27(5B):3465-3470